BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 25450979)

  • 21. Upregulation of CXCR4 favoring neural-like cells migration via AKT activation.
    Li S; Deng L; Gong L; Bian H; Dai Y; Wang Y
    Neurosci Res; 2010 Aug; 67(4):293-9. PubMed ID: 20412823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrin alpha4beta1 involvement in stromal cell-derived factor-1alpha-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion.
    Parmo-Cabañas M; Bartolomé RA; Wright N; Hidalgo A; Drager AM; Teixidó J
    Exp Cell Res; 2004 Apr; 294(2):571-80. PubMed ID: 15023543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma.
    Tai YT; Li X; Tong X; Santos D; Otsuki T; Catley L; Tournilhac O; Podar K; Hideshima T; Schlossman R; Richardson P; Munshi NC; Luqman M; Anderson KC
    Cancer Res; 2005 Jul; 65(13):5898-906. PubMed ID: 15994968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow stromal cell interaction reduces syndecan-1 expression and induces kinomic changes in myeloma cells.
    Fuhler GM; Baanstra M; Chesik D; Somasundaram R; Seckinger A; Hose D; Peppelenbosch MP; Bos NA
    Exp Cell Res; 2010 Jul; 316(11):1816-28. PubMed ID: 20307537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1α-induced invasion of human esophageal carcinoma cells.
    Lin ML; Lu YC; Chen HY; Lee CC; Chung JG; Chen SS
    Mol Carcinog; 2014 May; 53(5):360-79. PubMed ID: 23192861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stromal cell-derived factor-1α/C-X-C chemokine receptor type 4 axis promotes endothelial cell barrier integrity via phosphoinositide 3-kinase and Rac1 activation.
    Kobayashi K; Sato K; Kida T; Omori K; Hori M; Ozaki H; Murata T
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1716-22. PubMed ID: 24925969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells.
    Kijima T; Maulik G; Ma PC; Tibaldi EV; Turner RE; Rollins B; Sattler M; Johnson BE; Salgia R
    Cancer Res; 2002 Nov; 62(21):6304-11. PubMed ID: 12414661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and increases their susceptibility to Fas-mediated apoptosis.
    Badr G; Lefevre EA; Mohany M
    PLoS One; 2011; 6(9):e23741. PubMed ID: 21912642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1.
    Mirandola L; Apicella L; Colombo M; Yu Y; Berta DG; Platonova N; Lazzari E; Lancellotti M; Bulfamante G; Cobos E; Chiriva-Internati M; Chiaramonte R
    Leukemia; 2013 Jul; 27(7):1558-66. PubMed ID: 23354012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro cell behaviors of bone mesenchymal stem cells derived from normal and postmenopausal osteoporotic rats.
    Liu Q; Zhang X; Jiao Y; Liu X; Wang Y; Li SL; Zhang W; Chen FM; Ding Y; Jiang C; Jin Z
    Int J Mol Med; 2018 Feb; 41(2):669-678. PubMed ID: 29207050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simvastatin improves the homing of BMSCs via the PI3K/AKT/miR-9 pathway.
    Bing W; Pang X; Qu Q; Bai X; Yang W; Bi Y; Bi X
    J Cell Mol Med; 2016 May; 20(5):949-61. PubMed ID: 26871266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype.
    Beider K; Bitner H; Leiba M; Gutwein O; Koren-Michowitz M; Ostrovsky O; Abraham M; Wald H; Galun E; Peled A; Nagler A
    Oncotarget; 2014 Nov; 5(22):11283-96. PubMed ID: 25526031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4.
    Gazitt Y; Akay C
    Stem Cells; 2004; 22(1):65-73. PubMed ID: 14688392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide donor upregulation of stromal cell-derived factor-1/chemokine (CXC motif) receptor 4 enhances bone marrow stromal cell migration into ischemic brain after stroke.
    Cui X; Chen J; Zacharek A; Li Y; Roberts C; Kapke A; Savant-Bhonsale S; Chopp M
    Stem Cells; 2007 Nov; 25(11):2777-85. PubMed ID: 17641243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [SDF-1/CXCR4 and multiple myeloma osteolytic bone lesions--review].
    Bao L; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):442-6. PubMed ID: 18426683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia.
    Lu DY; Tang CH; Yeh WL; Wong KL; Lin CP; Chen YH; Lai CH; Chen YF; Leung YM; Fu WM
    Eur J Pharmacol; 2009 Jun; 613(1-3):146-54. PubMed ID: 19285061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion.
    Yu FX; Hu WJ; He B; Zheng YH; Zhang QY; Chen L
    World J Surg Oncol; 2015 Feb; 13():52. PubMed ID: 25890096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCR-7 receptor promotes SDF-1α-induced migration of bone marrow mesenchymal stem cells in the transient cerebral ischemia/reperfusion rat hippocampus.
    Wang Y; Fu W; Zhang S; He X; Liu Z; Gao D; Xu T
    Brain Res; 2014 Aug; 1575():78-86. PubMed ID: 24924806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR4 positive bone mesenchymal stem cells migrate to human endothelial cell stimulated by ox-LDL via SDF-1alpha/CXCR4 signaling axis.
    Li M; Yu J; Li Y; Li D; Yan D; Qu Z; Ruan Q
    Exp Mol Pathol; 2010 Apr; 88(2):250-5. PubMed ID: 20025867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A New Anti-CXCR4 Antibody That Blocks the CXCR4/SDF-1 Axis and Mobilizes Effector Cells.
    Broussas M; Boute N; Akla B; Berger S; Beau-Larvor C; Champion T; Robert A; Beck A; Haeuw JF; Goetsch L; Bailly C; Dumontet C; Matthes T; Corvaia N; Klinguer-Hamour C
    Mol Cancer Ther; 2016 Aug; 15(8):1890-9. PubMed ID: 27297868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.